Browse result page of THPdb

The total number entries retrieved from this search are 58

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1005	ThPPIDTh1002	NameCetuximab	Peptide SequenceHeavy chain:QVQLKQSG Full view	Length243	Functional ClassificationIIIc	DiseaseCancer	BrandErbitux	CompanyImClone Systems Inc	Physical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1028	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel	CompanyImmunex Corp	Physical AppearanceLyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1029	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel Sureclick	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1117	ThPPIDTh1016	NamePegfilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandNeulasta	CompanyAmgen Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-neutropenic agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1120	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeucomax	CompanyNovartis	Physical AppearanceSolution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1121	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeukine	CompanyBerlex Laboratories Inc	Physical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for Injection	Route of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV)	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1148	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAdvate	CompanyN.A.	Physical AppearancePowder form	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1149	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAlphanate	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1150	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandBioclate	CompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc.	Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1151	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHelixate FS	CompanyN.A.	Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHemofil M	CompanyN.A.	Physical AppearanceDry concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1153	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHyate:C	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1154	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKoate-HP	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1155	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKogenate FS	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1156	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonarc-M	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1157	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonoclate-P	CompanyN.A.	Physical AppearanceLyophilized powder for solution	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1158	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandReFacto	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1159	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandXyntha	CompanyN.A.	Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1205	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandHumulin R	CompanyEli Lilly and Company	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandNovolin R	CompanyNovo Nordisk	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1234	ThPPIDTh1032	NameCoagulation factor VIIa	Peptide SequenceANAFLEELRPGSLERECKEE Full view	Length255	Functional ClassificationIb	DiseaseHematological,Metabolic	BrandNovoSeven	CompanyNovo Nordisk	Physical AppearanceSterile, white lyophilized powder	Route of AdministartionInjection	CategoryThrombotic Agents, Coagulants	TargetCoagulation factor X,Serine protease hepsin,Tissue factor pathway inhibitor,Vitamin K-dependent gamma-carboxylase,Coagulation factor VII,Tissue factor
ID1246	ThPPIDTh1034	NamePalifermin	Peptide SequenceSYDYMEGGDIRVRRLFCRTQ Full view	Length140	Functional ClassificationIb	DiseaseCancer	BrandKepivance	CompanyAmgen Inc	Physical AppearanceSterile, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAnti-Mucositis Agents	TargetFibroblast growth factor receptor 2,Neuropilin-1,Fibroblast growth factor receptor 1,Fibroblast growth factor receptor 4,Fibroblast growth factor receptor 3,Basement membrane-specific heparan sulfate proteoglycan core protein
ID1275	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog	CompanyEli Lilly	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog KwikPen	CompanyEli Lilly	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1277	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog Pen	CompanyEli Lilly	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus	CompanySanofi-Aventis	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus OptiSet	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus SoloStar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1316	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseImmunological	BrandHumira	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous administration	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1317	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseOsteological	BrandHumira Pen	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1358	ThPPIDTh1050	NamePegademase bovine	Peptide SequenceMAQTPAFNKPKVELHVHLDG Full view	Length255	Functional ClassificationIa	DiseaseMetabolic	BrandAdagen	CompanyEnzon Inc.	Physical AppearanceIsotonic, pyrogen free, sterile solution, pH 7.2-7.4	Route of AdministartionIntramusular Injection	CategoryEnzyme Replacement Agents	TargetAdenosine,Growth factor receptor-bound protein 2
ID1368	ThPPIDTh1054	NameInfliximab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandREMICADE	CompanyCentocor Inc	Physical AppearanceSterile, white, lyophilized powder, following reconstitution with 10 mL of Sterile Water for Injection, USP, the resulting pH is approximately 7.2.	Route of AdministartionIntravenous infusion	CategoryAntirheumatic Agents, Anti-Inflammatory Agents, Non-Steroidal, Dermatologic Agents, Gastrointestinal Agents and Immunosuppressive Agents	TargetTumor necrosis factor
ID1382	ThPPIDTh1060	NameInsulin, porcine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	Brandvetsulin	CompanyIntervet Inc (Merck Animal Health)	Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension	Route of AdministartionSubcutaneous Injection	CategoryHypoglycemic Agents	TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1470	ThPPIDTh1092	NameArcitumomab	Peptide SequenceHeavy chain 1EVKLVES Full view	Length1310	Functional ClassificationIIb	DiseaseCancer	BrandCEA-Scan	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryDiagnostic Agents	TargetVascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
ID1474	ThPPIDTh1094	NamePanitumumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandVectibix	CompanyAmgen Inc	Physical AppearanceSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates	Route of AdministartionN.A.	CategoryN.A.	TargetEpidermal growth factor receptor
ID1475	ThPPIDTh1095	NameRanibizumab	Peptide SequenceLight Chain SASQDISN Full view	Length447	Functional ClassificationIIa	DiseaseHematological/Eye Disorder	BrandLucentis	CompanyGenentech	Physical AppearanceSterile, colorless to pale yellow solution	Route of AdministartionIntravitreal injection	CategoryOphthalmics	TargetVascular endothelial growth factor A
ID1480	ThPPIDTh1099	NameMecasermin	Peptide SequenceGPETLCGAELVDALQFVCGD Full view	Length70	Functional ClassificationIb	DiseaseHormonal	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor
ID1549	ThPPIDTh1118	NameSulodexide	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIc	DiseaseHormonal/genetic/Hematological/N.A.	BrandSULODEXIDE	CompanySyntex S.A	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents	TargetHeparin cofactor 2,Antithrombin-III
ID1570	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandXgeva	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1571	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandProlia	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1583	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceClear to slightly opalescent, colorless to light yellow solution	Route of AdministartionSubcutaneous injection	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1584	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceSterile concentrated solution of the golimumab antibody	Route of AdministartionIntravenous infusion	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1604	ThPPIDTh1130	NameBrentuximab Vedotin	Peptide SequenceHeavy chain:QIQLQQSG Full view	Length664	Functional ClassificationIIb	DiseaseCancer	BrandAdcetris	CompanySeattle Genetics	Physical AppearanceSterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetTumor necrosis factor receptor superfamily member 8
ID1609	ThPPIDTh1132	NameBelimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandBenlysta	CompanyGlaxoSmithKline	Physical AppearanceSterile, white to off-white, preservative-free, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 13B
ID1615	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandEylea	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, clear, and colorless to pale yellow solution.	Route of AdministartionIntravitreal injection	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1616	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandZaltrap	CompanySanofi and Regeneron Pharmaceuticals, Inc.	Physical AppearanceSterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1628	ThPPIDTh1139	NameCertolizumab Pegol	Peptide SequenceLight chain: DIQMTQS Full view	Length443	Functional ClassificationIIb	DiseaseImmunologcal	BrandCimzia	CompanyUCB	Physical AppearanceSterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Route of AdministartionSubcutaneous injection	CategoryTNF inhibitor	TargetTumor necrosis factor